Pediatric erosive esophagitis maintenance: Finally, some level 1 evidence!

American Journal of Gastroenterology

Volumn 102, Issue 6, 2007, Pages 1298-1300

  Orenstein, Susan R ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

BARRETT ESOPHAGUS; DISEASE SEVERITY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGITIS; ESOPHAGUS; ESOPHAGUS STRICTURE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HUMAN; MAINTENANCE THERAPY; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; REVIEW; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; ESOPHAGITIS, PEPTIC; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; RESEARCH DESIGN;

EID: 34249064615     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01148.x     Document Type: Review

References (18)

1. Hila A, Castell DO. Gastroesophageal reflux disease. Curr Treat Options Gastroenterol 2003 6 : 41 8.
2. Bak Y-T. Management strategies for gastroesophageal reflux disease. J Gastroenterol Hepatol 2004 19 : S49.
3. Hassall E. Decisions in diagnosing and managing chronic gastroesophageal reflux disease in children. J Pediatr 2005 146 : S3 S12.
4. Rudolph CD, Mazur LJ, Lipak GS, et al. Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: Recommendations of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 2001 32 (Suppl 2 S1 S31.
5. Boccia G, Manguso F, Miele E, et al. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable Am J Gastroenterol 2007 102 : 1291 7.
6. Dial S, Delaney JAC, Barkun AN, et al. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005 294 : 2989 95.
7. Guillet R, Stoll BJ, Cotton CM, et al. Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2006 117 : e137 42.
8. Canani RB, Cirillo P, Roggero P, et al. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics 2006 117 : e817 20.
9. Geevasinga N, Coleman PL, Webster AC, et al. Proton pump inhibitors and acute interstitial nephritis. Clin Gastroentero Hepatol 2006 4 : 597 604.
10. Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002 122 : 1500 11.
11. Hassall E, Kerr W, El-Serag HB. Characteristics of children receiving proton pump inhibitors continuously for up to 11 years duration. J Pediatr 2007 150 : 262 7.
12. Hassall E. Outcomes of fundoplication: Causes for concern, newer options. Arch Dis Child 2005 90 : 1047 52.
13. Hassall E. Barrett's esophagus: New definitions and approaches in children. J Pediatr Gastroenterol Nutr 1993 16 : 345 64.
14. Hassall E, Dimmick JE, Magee JF. Adenocarcinoma in childhood Barrett's esophagus: Case documentation and the need for surveillance in children. Am J Gastroenterol 1993 88 : 282 8.
15. Locke GR 2nd., Zinsmeister AR. Perils and pitfalls of small negative clinical trials. Am J Gastroenterol 2006 101 : 2185 6.
16. Davidson G, Omari T. Pathophysiological mechanisms of gastroesophageal reflux disease in children. Curr Gastroenterol Rep 2001 3 : 257 62.
17. McColl KEL. Acid inhibitory medication and risk of gastric and oesophageal cancer. Gut 2006 55 : 1532 3.
18. Metz DC. Therapy for gastroesophageal reflux disease: More is not necessarily better. Am J Gastroenterol 2003 98 : 1913 15.